279 related articles for article (PubMed ID: 37970478)
1. Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023).
Li YN; Xie B; Zhang Y; He MH; Xing Y; Mu DM; Wang H; Guo R
World J Gastroenterol; 2023 Oct; 29(40):5593-5617. PubMed ID: 37970478
[TBL] [Abstract][Full Text] [Related]
2. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials.
Xing Y; Yasinjan F; Du Y; Geng H; Zhang Y; He M; Guo R; Yang L; Cui J; Mu D; Liu Z; Wang H
Front Immunol; 2023; 14():1094437. PubMed ID: 36817443
[TBL] [Abstract][Full Text] [Related]
4. Visual analysis of global research on immunotherapy for gastric cancer: A literature mining from 2012 to 2022.
Chen Y; Chen Y; Tan S; Zheng Y; Liu S; Zheng T; Mi Y; Lin S; Yang C; Li W
Hum Vaccin Immunother; 2023 Dec; 19(1):2186684. PubMed ID: 37017186
[TBL] [Abstract][Full Text] [Related]
5. Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis.
Yuan Y; Su Y; Wu Y; Xue Y; Zhang Y; Zhang Y; Zheng M; Chang T; Qu Y; Zhao T
Front Oncol; 2023; 13():1229905. PubMed ID: 37671057
[TBL] [Abstract][Full Text] [Related]
6. Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.
Cheng K; Zhang H; Guo Q; Zhai P; Zhou Y; Yang W; Wang Y; Lu Y; Shen Z; Wu H
Front Immunol; 2022; 13():975695. PubMed ID: 36148235
[TBL] [Abstract][Full Text] [Related]
7. Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis.
Liu Y; Li S; Chen L; Lin L; Xu C; Qiu H; Li X; Cao H; Liu K
Front Immunol; 2024; 15():1341596. PubMed ID: 38380323
[TBL] [Abstract][Full Text] [Related]
8. Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer.
Zheng W; Wu Y; Wang Y; Cheng J; Shen W
Medicine (Baltimore); 2023 Jul; 102(27):e34228. PubMed ID: 37417594
[TBL] [Abstract][Full Text] [Related]
9. Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.
Liu YG; Jiang ST; Zhang L; Zheng H; Zhang T; Zhang JW; Zhao HT; Sang XT; Xu YY; Lu X
Eur J Med Res; 2023 Jul; 28(1):229. PubMed ID: 37430294
[TBL] [Abstract][Full Text] [Related]
10. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Immune-related adverse events: A bibliometric analysis.
Jiang ST; Liu YG; Zhang L; Sang XT; Xu YY; Lu X
Front Immunol; 2022; 13():1096806. PubMed ID: 36591239
[TBL] [Abstract][Full Text] [Related]
13. Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis.
Zhang L; Zheng H; Jiang ST; Liu YG; Zhang T; Zhang JW; Lu X; Zhao HT; Sang XT; Xu YY
Int J Surg; 2024 Mar; 110(3):1699-1710. PubMed ID: 38181123
[TBL] [Abstract][Full Text] [Related]
14. Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022.
Qu F; Wang G; Wen P; Liu X; Zeng X
Hum Vaccin Immunother; 2024 Dec; 20(1):2335728. PubMed ID: 38563136
[TBL] [Abstract][Full Text] [Related]
15. Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.
Su Y; Ruan Z; Wang R; Hao S; Tang Y; Huang X; Gao T; Li Z; Chang T
Front Immunol; 2022; 13():998217. PubMed ID: 36248874
[TBL] [Abstract][Full Text] [Related]
16. Bibliometric analysis of research trends and active research areas in chimeric antigen receptor T cell therapy for hematologic malignancies.
Zhang G; Deng L; Lu H; Zhang W
Int J Clin Pharm; 2024 Feb; 46(1):186-194. PubMed ID: 38087131
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the landscape of cytokine research in glioma immunotherapy: a scientometrics analysis.
Zhang H; Chen Y; Jiang X; Gu Q; Yao J; Wang X; Wu J
Front Pharmacol; 2023; 14():1333124. PubMed ID: 38259287
[No Abstract] [Full Text] [Related]
18. A comprehensive bibliometric analysis (2000-2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer.
Duan Y; Yang L; Wang W; Zhang P; Fu K; Li W; Yin R
Front Pharmacol; 2024; 15():1351363. PubMed ID: 38799160
[TBL] [Abstract][Full Text] [Related]
19. Bibliometric study on the knowledge graph of immunotherapy for head and neck cancer.
Wang J; Gong Z; Yu M
Front Oncol; 2023; 13():942777. PubMed ID: 36816940
[TBL] [Abstract][Full Text] [Related]
20. Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021.
Ou Z; Qiu L; Rong H; Li B; Ren S; Kuang S; Lan T; Lin H; Li Q; Wu F; Cai T; Yan L; Ye Y; Fan S; Li J
Front Immunol; 2022; 13():822004. PubMed ID: 35432345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
